Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer
Authors:
- So Yeon KimSKSo Yeon Kim
- Nam Kyu KimNKNam Kyu Kim
- Seung Hyuk BaikSBSeung Hyuk Baik
- Byung Soh MinBMByung Soh Min
- Hyuk HurHHHyuk Hur
- Jinae LeeJLJinae Lee
- Hyun-Young NohHNHyun-Young Noh
- Jong Ho LeeJLJong Ho Lee
- Bon-Nyeo KooBKBon-Nyeo Koo
Open Access
- 1 May 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (19) , e3602
Abstract
There has been a rising interest in the possible association between perioperative opioid use and postoperative outcomes in cancer patients. Continuous surgical wound infiltration with local anesthetics is a nonopioid analgesic technique that can be used as a postoperative pain management alternative to opioid-based intravenous patient-controlled analgesia (IV PCA). The aim of this study was to compare the effects of an opioid-based analgesic regimen versus a local anesthetic wound infiltration-based analgesic regimen on immune modulation and short-term cancer recurrence or metastasis in patients undergoing laparoscopic resection of colorectal cancer. Sixty patients undergoing laparoscopic resection of colorectal cancer were randomly assigned to either the opioid group or the ON-Q group. For postoperative analgesia during the first 48 hours, the opioid group (n = 30) received fentanyl via IV PCA, whereas the ON-Q group (n = 30) received continuous wound infiltration of 0.5% ropivacaine with an ON-Q pump and tramadol via IV PCA. Pethidine for the opioid group and ketorolac or propacetamol for the ON-Q group were used as rescue analgesics. Anesthesia was induced and maintained with propofol and remifentanil. The primary outcome was postoperative immune function assessed by natural killer cell cytotoxicity (NKCC) and interleukin-2. Secondary outcomes were postoperative complications, cancer recurrence, or metastasis within 1 year after surgery, and postoperative inflammatory responses measured by white blood cell count, neutrophil percentage, and C-reactive protein. Immune function and inflammatory responses were measured before surgery and 24 and 48 hours after surgery. Fifty-nine patients completed the study. In the circumstance of similar pain control efficacy between the opioid group and the ON-Q group, postoperative NKCC and interleukin-2 levels did not differ between the 2 groups. The incidence of postoperative complications and recurrence or metastasis within 1 year after surgery was comparable between the groups. Postoperative inflammatory responses were also similar between the groups. When compared with ropivacaine wound infiltration-based analgesia, fentanyl-based analgesia did not further decrease NKCC or affect short-term cancer recurrence or metastasis. Thus, a fentanyl-based analgesic regimen and a ropivacaine wound infiltration-based analgesic regimen can both be used for postoperative pain management in laparoscopic resection of colorectal cancer.Keywords
This publication has 36 references indexed in Scilit:
- NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cellsBMC Cancer, 2013
- Beneficial immunostimulatory effect of short-term Chlorella supplementation: enhancement of Natural Killercell activity and early inflammatory response (Randomized, double-blinded, placebo-controlled trial)Nutrition Journal, 2012
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- Association between Epidural Analgesia and Cancer Recurrence after Colorectal Cancer SurgeryAnesthesiology, 2010
- Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer RecurrenceAnesthesiology, 2008
- Long-Term Survival After Colon Cancer Surgery: A Variation Associated with Choice of AnesthesiaAnesthesia & Analgesia, 2008
- Review article: immune suppression and colorectal cancerAlimentary Pharmacology & Therapeutics, 2006
- Patient-Controlled AnalgesiaAnesthesia & Analgesia, 2005
- Intravenous Fentanyl Increases Natural Killer Cell Cytotoxicity and Circulating CD16+ Lymphocytes in HumansAnesthesia & Analgesia, 2002
- Effects of Anesthesia Based on Large Versus Small Doses of Fentanyl on Natural Killer Cell Cytotoxicity in the Perioperative PeriodAnesthesia & Analgesia, 1996